Aggression - 371 Studies Found
| Completed |
: Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin : Type 2 Diabetes : 2009-05-08 : Drug: Levemir (Detemir) and Novolog (Aspart) Insulin Will use individualized doses of levemir (detemir) |
| Active, not recruiting |
: SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD : Sickle Cell Disease : 2013-12-11 :
|
| Active, not recruiting |
: Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD) : Coronary Artery Disease : 2010-01-05 : Drug: Pitavastatin 1 mg daily or 4 mg daily Patients who met all inclusion criteria and did not meet exc |
| Completed |
: PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma :
: 2006-03-15 : Drug: belinostat Given IV Other Name: PXD101 |
| Completed |
: Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD) : Sickle Cell Disease : 2011-11-23 :
|
| Completed |
: CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr : Prostate Cancer : 2016-02-12 : Other: MRI VERDICT diffusion-weighted microstructure imaging sequence |
| Suspended |
: A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas :
|
| Completed |
: Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma : Lymphoma, Non-Hodgkin : 2002-08-30 : Drug: Taxane (Cytotoxic, BAY59-8862) Daily 1 h infusion every 3 weeks |
| Terminated |
: Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice : Smoking Cessation : 2013-04-08 : Other: Aggressive Therapy Pharmacotherapy adjuncts offered |
| Completed |
: Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas :
: 2002-05-02 : Drug: BCX-1777 |